Anthem Blue Cross (HMO, PPO, EPO)
Zejula (niraparib)
Drugs for Cancer : Drugs for Cancer
  • Step Therapy: Chronic Kidney Disease:
    Step Therapy Applies

  • Prior Authorization: Multiple Sclerosis (MS):
    Documented Diagnosis: Yes
    Age Requirement: >= 18
    Duration: 6 Month(s)
    Reauthorization Required: Yes

  • 1;
  • PA**;
  • Immune Thrombocytopenic Purpura (ITP):
    Age Requirement: >= 18
    Duration: 6 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Specialist Type(s): Hematologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Diagnosis Types: Chronic Immune Thrombocytopenia
    Baseline Platelet Count: 1 of < 30,000/mcL;Active bleed
    Risk of Bleeding as defined in policy: As indicated by platelet count < 30,000/mcL
    Reauthorization Requirements Documented in Policy: 2 of Meet Initial Criteria;Response to therapy as evidenced by increased platelet count
    Required Medical Information: 3 of Chart Notes;Lab Results;Platelet count
    Supporting Documentation Must Be Submitted: Yes